DISCOUNT ZERTIFIKAT - VERTEX PHARMACEUTICALS | Real-time Bid/Ask 12:04:56 2024-06-10 EDT | ||
| 359.71 EUR / 360.04 EUR | +0.49% |
|
| Current month | +1.95% | ||
| 1 month | +4.22% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about VERTEX PHARMACEUTICALS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-10 | 360.4 | +0.63% |
| 24-06-07 | 358.1 | +0.79% |
| 24-06-06 | 355.3 | -0.03% |
| 24-06-05 | 355.4 | +0.64% |
| 24-06-04 | 353.1 | -0.02% |
Delayed Quote Börse Stuttgart
Last update June 10, 2024 at 06:48 am
More quotesStatic data
| Product type | Certificats Discount |
|---|---|
| Buy / Sell | CALL |
| Underlying | VERTEX PHARMACEUTICALS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | ME7D8R |
| ISIN | DE000ME7D8R8 |
| Date issued | 2024-01-23 |
| Cap | 400 $ |
| Last trading day | 2024-12-20 |
| Maturity | 2024-12-20 (193 Days) |
| Parity | 1 : 1 |
| Emission price | 337 € |
| Emission volume | N/A |
| Payment day | 2024-12-31 |
| Bonus | - € |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Discount (ask) | 19.39 % |
|---|---|
| Sideways yield | 3.366 % |
| Sideways yield pa | 6.365 % |
| Outperformance point | 496.2 $ |
| Break even | 386.98 € |
| Highest since issue | 360.4 € |
| Lowest since issue | 328.6 € |
| Spread | 0.33 € |
| Spread % | 0.09% |
| Distance Cap | 80.55 $ |
| Distance Cap % | +16.76% |
| Max. earning | 12.12 |
| Max. earning % | 3.366 % |
Company Profile
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases.
Net sales are distributed geographically as follows: the United States (61.2%), Europe (31.5%) and other (7.3%).
Sector
-
Ratings for Vertex Pharmaceuticals Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Vertex Pharmaceuticals Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
483
USD
Average target price
463.5
USD
Spread / Average Target
-4.04%
- Stock Market
- Certificates
- Certificat
